The Ryan Institute for Neuroscience is dedicated to the prevention and treatment of neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), aging-related illness, and other central nervous system disorders.
Recent News
$413,729 NIH grant helps to study the link between stroke and Alzheimer’s disease January 4, 2024 - Assistant Professor Claudia Fallini hopes the research will lead to new Alzheimer's disease insights and improved stroke outcomes. 
Van Nostrand lab collaborates with Eli Lilly to investigate brain bleed risk in Alzheimer’s disease treatments January 2, 2024 - The project will help shed light on whether there may be a way to reduce or eliminate the risk.
$8.5 million in NIH grants support Ryan Institute research to help treat cerebral palsy September 9, 2023 - Assistant Professor Katharina Quinlan is principal investigator on two new grants that could repurpose existing therapeutics to treat the disorder.
A new study investigates the impact of microplastics in the brain August 4, 2023 - Assistant Professor Jaime Ross and her lab report surprising findings on the impact of short-term microplastics exposure through drinking water.
We’re hiring
Are you a mid-career researcher in the field of Alzheimer’s disease and related disorders?
“Solving neurodegenerative disease is going to be a global effort. But if we work together, we can have a much better result.”Tom Ryan ‘75, Hon. ‘99